JBTM vs. SYM: Which Stock Is the Better Value Option? — Positive
JBTM SYM Zacks Investment Research — November 10, 2025Investors with an interest in Technology Services stocks have likely encountered both JBT Marel (JBTM) and Symbotic Inc. (SYM). But which of these two companies is the best option for those looking for undervalued stocks?
CIB vs. FSS: Which Stock Is the Better Value Option? — Positive
CIB FSS Zacks Investment Research — November 10, 2025Investors looking for stocks in the Diversified Operations sector might want to consider either Grupo Cibest (CIB) or Federal Signal (FSS). But which of these two companies is the best option for those looking for undervalued stocks?
Air Products and Chemicals (APD) Could Be a Great Choice — Positive
APD Zacks Investment Research — November 10, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Air Products and Chemicals (APD) have what it takes?
Why Kroger (KR) is a Great Dividend Stock Right Now — Positive
KR Zacks Investment Research — November 10, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Kroger (KR) have what it takes?
Meta's Plunge Looks Tempting, But It's No Opportunity (Downgrade) — Negative
META Seeking Alpha — November 10, 2025Meta Platforms, Inc.'s 20% stock plunge reflects a rational market re-pricing rather than an emotional selloff. Despite strong Q3 growth, Meta's topline expansion is clearly decelerating due to its already saturated user base. Future growth depends heavily on monetization per user, which faces natural limits and sustainability concerns.
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRX — Neutral
MRX Newsfile Corp — November 10, 2025New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Marex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Berkshire's Buffett to Keep Class A Stock Until Investors Get Comfort With Successor — Neutral
BRK-A BRK-B WSJ — November 10, 2025Warren Buffett shares his thoughts on his career and Berkshire's future in a letter.
Wall Street is Pounding the Table Over NVDA, RUN, LLY — Neutral
LLY NVDA RUN 24/7 Wall Street — November 10, 2025In addition, according to analysts at UBS, it sees Nvidia guiding fourth quarter revenue to a range of $63 billion to $64 billion.
Cavco Industries is upgraded to a soft "Buy" due to its resilience and growth despite broader housing market weakness. CVCO's niche in factory-built homes, recent acquisition of American Homestar, and strong backlog support continued expansion. The company boasts a fortress balance sheet with no debt and significant cash reserves, enhancing its financial stability.
From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside — Positive
QURE Seeking Alpha — November 10, 2025UniQure stock is rated a Buy with a $66 price target, offering upside after recent FDA pushback on AMT-130 Huntington's therapy trial design. AMT-130 is the first disease-modifying therapy for Huntington's, showing 75% slowing of disease progression and significant functional benefit in Phase 1/2 data. Modeling suggests a 78% probability of eventual approval (accelerated or post-Phase 3), with near-term catalysts including FDA meeting minutes and EMA discussions.
Papa John's stock higher on go-private report — Positive
PZZA Proactive Investors — November 10, 2025Papa John's International Inc (NASDAQ:PZZA) shares gained 5% to $43.05 on Monday following a report that the pizza maker is in advanced discussions with TriArtisan Capital to be taken private at $65 per share, according to ABC Money UK, which cited people familiar with the talks. The potential acquisition price would value Papa John's at $2.7 billion.
An Earnings Win With a Stock Slump: What's Happening With D-Wave? — Neutral
QBTS MarketBeat — November 10, 2025One of the most-hyped earnings reports of the quantum industry this season ended not with a rally, but a retreat. Shares of D-Wave Quantum Inc. NYSE: QBTS fell by nearly 22% in the first full week of trading in November 2025, closing the week under $30 per share.
Bakkt Holdings, Inc. (BKKT) Q3 2025 Earnings Call Transcript — Neutral
BKKT Seeking Alpha — November 10, 2025Bakkt Holdings, Inc. ( BKKT ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Cody Fletcher Akshay Naheta - CEO & Director Karen Alexander - CFO & Principal Financial Officer Conference Call Participants Chris Brendler Mark Palmer - The Benchmark Company, LLC, Research Division Justin Pan Presentation Operator Greetings, and welcome to the Bakkt's Third Quarter 2025 Earnings Conference Call. [Operator Instructions].
Lithium Argentina AG (LAR:CA) Q3 2025 Earnings Call Transcript — Neutral
LAR Seeking Alpha — November 10, 2025Lithium Argentina AG ( LAR:CA ) Q3 2025 Earnings Call November 10, 2025 8:00 AM EST Company Participants Kelly O'Brien - VP of Investor Relations & ESG Sam Pigott - CEO, President & Director Xiaoshen Wang - President & Vice Chairman Jason Luo Carlos Galli - Chief Operating Officer Conference Call Participants Joel Jackson - BMO Capital Markets Equity Research Katie Lachapelle - Canaccord Genuity Corp., Research Division Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Corinne Blanchard - Deutsche Bank AG, Research Division David Deckelbaum - TD Cowen, Research Division Mohamed Sidibe - National Bank Financial, Inc., …
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at UBS Global Healthcare Conference 2025 Transcript — Neutral
ALNY Seeking Alpha — November 10, 2025Alnylam Pharmaceuticals, Inc. ( ALNY ) UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST Company Participants Jeffrey Poulton - CFO & Executive VP John Vest - Senior Vice President of Clinical Research Conference Call Participants Ashwani Verma - UBS Investment Bank, Research Division Presentation Ashwani Verma UBS Investment Bank, Research Division All right. Good day, everybody.
PowerFleet, Inc. (AIOT) Q2 2026 Earnings Call Transcript — Neutral
AIOT Seeking Alpha — November 10, 2025PowerFleet, Inc. ( AIOT ) Q2 2026 Earnings Call November 10, 2025 8:30 AM EST Company Participants Steve Towe - CEO & Director Jeffrey Lautenbach - Chief Revenue Officer David Wilson - CFO & Corporate Secretary Melissa Ingram - Chief Corporate Development Officer Conference Call Participants Carolyn Capaccio - Alliance Advisors, LLC Scott Searle - ROTH Capital Partners, LLC, Research Division Anthony Stoss - Craig-Hallum Capital Group LLC, Research Division Gary Prestopino - Barrington Research Associates, Inc., Research Division Dylan Becker - William Blair & Company L.L.C., Research Division Alexander Sklar - Raymond James & Associates, Inc., Research Division Gregory …
Pan American Silver Set to Report Q3 Earnings: Here's What to Expect — Positive
PAAS Zacks Investment Research — November 10, 2025PAAS gears up to report Q3 results, with sales projected to jump 21% y/y and earnings expected to rise 53%.
3 Top Warren Buffett Picks that Will Stand the Test of Time — Positive
AAPL BAC BRK-B KO 24/7 Wall Street — November 10, 2025Warren Buffett is undoubtedly going to go down in the history books as one of the best investors of all time.
Tesla shares jump as Cybertruck chief exits company — Positive
TSLA Proactive Investors — November 10, 2025Tesla Inc (NASDAQ:TSLA) shares added almost 4% after it was announced that the head of its divisive Cybertruck unit, Siddhant Awasthi, is departing the company after eight years. Awasthi began his career at Tesla as an intern in 2017 and eventually led the Cybertruck program from engineering through mass production.
Chenghe Acquisition III Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on November 11, 2025 — Neutral
CHECU GlobeNewsWire — November 10, 2025Singapore, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Chenghe Acquisition III Co. (the “Company”) today announced that, commencing on November 11, 2025, holders of the units (the “Units”) sold in the Company's initial public offering may elect to separately trade the Company's Class A Ordinary Shares (the “Shares”) and warrants (the “Warrants”) included in the Units.